Promoting Quality in Drug Manufacturing

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2004
Volume 28
Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8